por
How, Joan,
Gallagher, Kathleen M.E.,
Liu, Yiwen,
DeMato, Ashley,
Katsis, Katelin,
Larson, Rebecca,
Leick, Mark B.,
Neuberg, Donna S.,
Maus, Marcela V.,
Hobbs, Gabriela
Publicado 2021
“…Maus: Atara: Consultancy; Bayer: Consultancy; BMS: Consultancy;
Cabaletta Bio (SAB): Consultancy; CRISPR therapeutics: Consultancy; In8bio (SAB): Consultancy; Intellia: Consultancy; GSK: Consultancy; Kite Pharma: Consultancy, Research Funding; Micromedicine: Consultancy, Current holder of stock options in a privately-held company; Novartis: Consultancy; Tmunity: Consultancy; Torque: Consultancy, Current holder of stock options in a privately-held company; WindMIL: Consultancy; AstraZeneca: Consultancy; Agenus: Consultancy; Arcellx: Consultancy; Astellas: Consultancy; Adaptimmune: Consultancy; tcr2: Consultancy, Divested equity in a private or publicly-traded company in the past 24 months; century: Current equity holder in publicly-traded company; ichnos biosciences: Consultancy, Current holder of stock options in a privately-held company. …”
Enlace del recurso
Enlace del recurso
Online
Artículo
Texto